Olof Breuer

Publikationer
Populärvetenskap och samverkan

Artiklar

Article: BIOMEDICINES. 2023;11(2):295
Intravenous Infusion of High Dose Selenite in End-Stage Cancer Patients: Analysis of Systemic Exposure to Selenite and Seleno-Metabolites
Breuer O; Brodin O; Razaghi A; Brodin D; Gammelgaard B; Bjoernstedt M
Article: LANCET PSYCHIATRY. 2022;9(6):447-457
Improving lithium dose prediction using population pharmacokinetics and pharmacogenomics: a cohort genome-wide association study in Sweden
Millischer V; Matheson GJ; Bergen SE; Coombes BJ; Ponzer K; Wikstrom F; Jagiello K; Lundberg M; Stenvinkel P; Biernacka JM; Breuer O; Martinsson L; Landen M; Backlund L; Lavebratt C; Schalling M
Article: MYCOSES. 2022;65(1):79-87
Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?
Kurland S; Lowdin E; Furebring M; Shams A; Chryssanthou E; Lagerback P; Tangden T; Breuer O; Sjolin J
Article: JOURNAL OF LIPID RESEARCH. 2014;55(11):2408-2415
Thyroid hormone reduces PCSK9 and stimulates bile acid synthesis in humans
Bonde Y; Breuer O; Luetjohann D; Sjoberg S; Angelin B; Rudling M
Article: EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY. 2013;69(3):467-475
VKORC1-dependent pharmacokinetics of intravenous and oral phylloquinone (vitamin K1) mixed micelles formulation.
Marinova M; Lütjohann D; Breuer O; Kölsch H; Westhofen P; Watzka M; Mengel M; Stoffel-Wagner B; Hartmann G; Coch C; Oldenburg J
Article: ANESTHESIOLOGY. 2007;106(1):43-55
Pharmacokinetics of ropivacaine in patients with chronic end-stage liver disease
Jokinen MJ; Neuvonen PJ; Lindgren L; Hockerstedt K; Sjovall J; Breuer O; Askemark Y; Ahonen J; Olkkola KT
Article: JOURNAL OF PHARMACY AND PHARMACOLOGY. 2005;57(5):587-597
Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1997;272(48):30178-30184
Importance of a novel oxidative mechanism for elimination of brain cholesterol - Turnover of cholesterol and 24(S)-hydroxycholesterol in rat brain as measured with O-18(2) techniques in vivo and in vitro
Bjorkhem I; Lutjohann D; Breuer O; Sakinis A; Wennmalm A
Article: BIOCHEMICAL JOURNAL. 1997;323(Pt 3):853-858
Transformation of subcutaneous nitric oxide into nitrate in the rat
Benthin G; Bjorkhem I; Breuer O; Sakinis A; Wennmalm A
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1996;93(18):9799-9804
Cholesterol homeostasis in human brain: Evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation
Lutjohann D; Breuer O; Ahlborg G; Nennesmo I; Siden A; Diczfalusy U; Bjorkhem I
Article: BIOCHIMICA ET BIOPHYSICA ACTA: INTERNATIONAL JOURNAL OF BIOCHEMISTRY AND BIOPHYSICS. 1996;1302(2):145-152
The oxysterols cholest-5-ene-3 beta,4 alpha-diol, cholest-5-ene-3 beta,4 beta-diol and cholestane-3 beta,5 alpha,6 alpha-triol are formed during in vitro oxidation of low density lipoprotein, and are present in human atherosclerotic plaques
Breuer O; Dzeletovic S; Lund E; Diczfalusy U
Article: JOURNAL OF LIPID RESEARCH. 1995;36(11):2275-2281
IDENTIFICATION AND QUANTITATION OF CHOLEST-5-ENE-3-BETA,4-BETA-DIOL IN RAT-LIVER AND HUMAN PLASMA
BREUER O
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1995;270(35):20278-20284
USE OF AN O-18(2) INHALATION TECHNIQUE AND MASS ISOTOPOMER DISTRIBUTION ANALYSIS TO STUDY OXYGENATION OF CHOLESTEROL IN RAT - EVIDENCE FOR IN-VIVO FORMATION OF 7-OXOCHOLESTEROL, 7-BETA-HYDROXYCHOLESTEROL, 24-HYDROXYCHOLESTEROL, AND 24-HYDROXYCHOLESTEROL
BREUER O; BJORKHEM I
Article: ANALYTICAL BIOCHEMISTRY. 1995;225(1):73-80
DETERMINATION OF CHOLESTEROL OXIDATION-PRODUCTS IN HUMAN PLASMA BY ISOTOPE-DILUTION MASS-SPECTROMETRY
DZELETOVIC S; BREUER O; LUND E; DICZFALUSY U
Journal article: FEBS JOURNAL. 1993;215(3):705-710
CHOLESTEROL 7-ALPHA-HYDROXYLASE IS UP-REGULATED BY THE COMPETITIVE INHIBITOR 7-OXOCHOLESTEROL IN RAT-LIVER
BREUER O; SUDJANASUGIAMAN E; EGGERTSEN G; CHIANG JYL; BJORKHEM I
Journal article: JOURNAL OF BIOLOGICAL CHEMISTRY. 1992;267(35):25092-25097
EVIDENCE THAT 24-HYDROXYLATION AND 27-HYDROXYLATION ARE NOT INVOLVED IN THE CHOLESTEROL-INDUCED DOWN-REGULATION OF HYDROXYMETHYLGLUTARYL-COA REDUCTASE IN MOUSE-LIVER
LUND E; BREUER O; BJORKHEM I
Journal article: ARTERIOSCLEROSIS AND THROMBOSIS. 1991;11(1):15-22
THE ANTIOXIDANT BUTYLATED HYDROXYTOLUENE PROTECTS AGAINST ATHEROSCLEROSIS
BJORKHEM I; HENRIKSSONFREYSCHUSS A; BREUER O; DICZFALUSY U; BERGLUND L; HENRIKSSON P
Journal article: STEROIDS. 1990;55(4):185-192
SIMULTANEOUS QUANTIFICATION OF SEVERAL CHOLESTEROL AUTOXIDATION AND MONOHYDROXYLATION PRODUCTS BY ISOTOPE-DILUTION MASS-SPECTROMETRY
BREUER O; BJORKHEM I
Journal article: JOURNAL OF LIPID RESEARCH. 1988;29(8):1031-1038
ASSAY OF UNESTERIFIED CHOLESTEROL-5,6-EPOXIDE IN HUMAN-SERUM BY ISOTOPE-DILUTION MASS-SPECTROMETRY - LEVELS IN THE HEALTHY STATE AND IN HYPERLIPOPROTEINEMIA
BJORKHEM I; BREUER O; ANGELIN B; WIKSTROM SA
Journal article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1987;142(3):667-673
ENZYMATIC CONVERSION OF LEUKOTRIENE B-4 TO 6-TRANS-LEUKOTRIENE B-4 BY RAT-KIDNEY HOMOGENATES
BREUER O; HAMMARSTROM S

Alla övriga publikationer

Meeting abstract: BLOOD. 2024;144:6010
A Phase I/II Study Investigating Karonudib in Patients with Refractory Haematological Malignancies
Deneberg S; Uggla B; Smith A; Sandvall T; Klockare M; Breuer O; Berglund UW; Helleday T
Meeting abstract: CANCER RESEARCH. 2023;83(8_Supplement):ct182
Abstract CT182: OXC-101 shows favorable safety profile in first in human phase 1 trial in patients with advanced solid cancer
Yachnin J; Ny L; Sandvall T; Sanjiv K; Scobie M; Platzack B; Barancewski P; Breuer O; Gorgoulis V; Pateras IS; Klockare M; Smith A; Berglund UW; Helleday T
Book chapter: NATURAL ANTIOXIDANTS AND FOOD QUALITY IN ATHEROSCLEROSIS AND CANCER PREVENTION. 1996;p. 11-17
Oxysterols and Atherosclerosis - A Minireview
Björkhem I; Breuer O; Diczfalusy U; Lund E

Artiklar

Alla övriga publikationer

Nyheter från KI

Kalenderhändelser från KI